• Optimal Treatment for Ventricular Tachycardia: Catheter Ablation vs. Antiarrhythmic Drugs

  • Dec 8 2024
  • Length: 10 mins
  • Podcast

Optimal Treatment for Ventricular Tachycardia: Catheter Ablation vs. Antiarrhythmic Drugs

Listen for free

View show details

  • Summary

  • In this episode, we take a closer look at the VANISH2 study, a groundbreaking piece of research recently published in The New England Journal of Medicine. This study tackles a crucial question: should patients with ischemic cardiomyopathy and ventricular tachycardia start treatment with catheter ablation or antiarrhythmic drugs? We’ll break down the key findings, including how ablation seemed to outperform medication in reducing ICD shocks and improving survival rates. But what do these results mean for doctors and patients in real-life settings? Tune in as we explore the practical implications and discuss what might change in how we manage this serious heart condition.
    Show More Show Less
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Optimal Treatment for Ventricular Tachycardia: Catheter Ablation vs. Antiarrhythmic Drugs

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available